EQUITY RESEARCH MEMO

TrueBlue Clinical Research

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)65/100

TrueBlue Clinical Research is a privately held clinical trial site based in Tampa, Florida, with over 100 years of cumulative research experience. Founded in 2006, the company specializes in multi-specialty Phase Ib–IV studies, serving sponsors and patients with high-quality, dependable, and inclusive clinical trial services. As a dedicated site, TrueBlue plays a critical role in the clinical development ecosystem, offering expertise across therapeutic areas and ensuring patient access to innovative treatments. With a focus on operational excellence and patient-centricity, the company is well-positioned to capture the growing demand for decentralized and site-based trials, particularly in the southeastern United States.

Upcoming Catalysts (preview)

  • Q2 2026Award of new clinical trial contracts from pharmaceutical sponsors75% success
  • Q4 2026Completion of a pivotal study with potential FDA filing50% success
  • TBDExpansion of therapeutic capabilities or site capacity60% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)